By Professor Leslie Burnett

Journal articles

Burnett L, 2004, 'Making national DNA databases safer. (vol 362, pg 1761, 2003)', LANCET, 363, pp. 902 - 902, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220231500047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKenzie S; Deane EM; Burnett L, 2004, 'Are serum cortisol levels a reliable indicator of wellbeing in the tammar wallaby, Macropus eugenii?', Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 138, pp. 341 - 348

Howell VM; Proos AL; LaRue D; Jensen CH; Beach F; Burnett L, 2004, 'Carrier screening for Canavan disease in Australia.', Journal of inherited metabolic disease, 27, pp. 289 - 290

Burnett L; Chesher D; Mudaliar Y, 2004, 'Improving the quality of information on pathology request forms.', Ann Clin Biochem, 41, pp. 53 - 56

Barlow-Stewart K; Burnett L; Proos AL; Howell VM; Huq F; Lazarus R; Aizenberg H, 2003, 'A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.', Journal of medical genetics, 40, pp. e45 - e45

Burnett L, 2003, 'Making national DNA databases safer.', Lancet, 362, pp. 1761 - 1762

Burnett L; Barlow-Stewart K; Proos AL; Aizenberg H, 2003, 'The "GeneTrustee": a universal identification system that ensures privacy and confidentiality for human genetic databases.', Journal of law and medicine, 10, pp. 506 - 513

McKenzie S; Deane EM; Burnett L, 2002, 'Haematology and Serum Biochemistry of the Tammar Wallaby, Macropus eugenii', Comparative Clinical Pathology, 11, pp. 229 - 237

Groot-Obbink D; Hegedus G; Mackay MA; Proos AL; Burnett L; Chesher D; Rochester C; Shaw W; Webber A, 2002, 'ISO compliant laboratory quality systems and incident monitoring improve the implementation of laboratory information systems', Accred Qual Assur, 7, pp. 237 - 241

Burnett L; Chesher D; Burnett JR, 2002, 'Optimizing the availability of ’stat’ laboratory tests using Shewhart ’C’ control charts.', Ann Clin Biochem, 39, pp. 140 - 144

Burnett L, 2001, 'EBM in the laboratory', The Medical Journal of Australia

Bahar A; Taylor P; Andrews L; Proos AL; Burnett L; Tucker K; Friedlander M; Buckley M, 2001, 'The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data', Cancer, 92, pp. 440 - 445

Burnett L, 2000, 'Community genetics testing programs in Australia', Australian Journal of Medical Science, 21, pp. 50

Burnett L, 2000, 'Customer-focussed design of integrated laboratories', Australian Journal of Medical Science, 21, pp. 51

Burnett L, 2000, 'Genetics broker- the simple solution to the DNA debate', The Sydney Morning Herald, pp. 17 - 17

Watts B; Burnett L; Chesher D, 2000, 'Measurement of total protein is not a useful inclusion in liver function test profiles', Clinical Chemistry, 46, pp. 1022 - 1023

Goodrich ME; Goodrich ME; Cumming RG; Mitchell P; Koutts J; Burnett L, 1999, 'Plasma fibrinogen and other cardiovascular disease risk factors and cataract.', Ophthalmic Epidemiology, 6, pp. 279 - 290

Mitchell P; Smith W; Cumming RG; Leeder SR; Burnett L, 1998, 'Diabetes in an older Australian population', Diabetes Res Clin Pract, 41, pp. 177 - 184

Tsang CW; Tsang CW; Lazarus R; Smith W; Mitchell P; Koutts J; Burnett L, 1998, 'Hematological indices in an older population sample: derivation of healthy reference values', Clinical Chemistry, 44, pp. 96 - 101

Burnett L, 1998, 'Taking charge', The Medical Journal of Australia

Chesher D; Burnett L, 1997, 'Equivalence of critical error calculations and process capability index C-pk', CLINICAL CHEMISTRY, 43, pp. 1100 - 1101, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XC89800046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chesher D; Burnett L, 1997, 'Equivalence of critical error calculations and process capability index Cpk.', Clinical chemistry, 43, pp. 1100 - 1101, http://dx.doi.org/10.1093/clinchem/43.6.1100

Chesher D; Burnett L, 1997, '\textbfEquivalence of Critical Error \textbfCalculations and Process Capability \textbfIndex C pk ', Clinical Chemistry, 43, pp. 1100 - 1101

Burnett L; Rochester C; Mackay MA; Proos AL, 1997, 'Implementation of ISO 9001 in a medical testing laboratory', Accred Qual Assur, 2, pp. 76 - 81

Deane EM; Basden K; Burnett L; Proos AL; Cooper D, 1997, 'Serum analytes in the Tammar wallaby, Macropus eugenii', Aust Vet J, 75, pp. 141 - 142

Hall GH; Hamilton WT, 1996, 'Genetic testing.', Lancet, 347, pp. 685, https://www.ncbi.nlm.nih.gov/pubmed/8596392

Tan M-HH; Commens CA; Burnett L; Snitch PJ, 1996, 'A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens.', The Australasian journal of dermatology, 37, pp. 185 - 187

Burnett L; Hegedus G; Chesher D; Burnett JR; Costaganna G, 1996, 'Application of process capability indices to quality control in a clinical chemistry laboratory', Clinical Chemistry, 42, pp. 2035 - 2037

Burnett L; Khoury M; Mackay MA, 1996, 'Error rates in Australian chemical pathology laboratories', The Medical Journal of Australia, 165, pp. 582 - 584

Khoury M; Burnett L; Mackay MA, 1996, 'Error rates in Australian chemical pathology laboratories.', The Medical Journal of Australia, 165, pp. 128 - 130

Howell VM; Burnett L, 1996, 'Genetic testing', Lancet, 347, pp. 685 - 686

Chesher D; Burnett L, 1996, 'Using Shewhart p control charts of external quality-assurance program data to monitor analytical performance of a clinical chemistry laboratory', Clinical Chemistry, 42, pp. 1478 - 1482

Burnett L; Chesher D, 1995, 'Application of CQI tools to the reduction in risk of needlestick injury.', Infection control and hospital epidemiology, 16, pp. 503 - 505

Giamboi E; Burnett L; Shaw W, 1995, 'Improving Laboratory Turnaround Time', CQI Annual, pp. 117 - 120

Siafakas N; Burnett L; Bennetts BH; Proos AL, 1995, 'Nonenzymatic extraction of DNA from blood collected into serum separator tubes.', Clinical Chemistry, 41, pp. 1045 - 1046

Brillante R; Brillante R; Yang V; Yang V; Proos AL; Burnett L, 1995, 'PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.', Clinical Chemistry, 41, pp. 321 - 322

Chesher D; Burnett L, 1995, 'Simple computer spreadsheet for standardized interpretation of oral glucose tolerance tests.', Pathology, 27, pp. 140 - 141

Burnett L; Proos AL; Chesher D; Howell VM; Longo L; Longo L; Tedeschi V; Tedeschi V; Yang VA; Yang VA; Siafakas N; Turner G, 1995, 'The Tay-Sachs disease prevention program in Australia: Sydney pilot study.', The Medical Journal of Australia, 163, pp. 298 - 300

Burnett L, 1994, 'Applying the Australian Quality Award Assessment Criteria to Clinical Biochemistry', The Clinical Biochemist Newsletter, 113, pp. 29 - 31

Burnett L, 1994, 'Applying the Australian Quality Awards criteria to a clinical chemistry department', Qual Manag Health Care, 3, pp. 1 - 15

Burnett L; Burnett L, 1994, 'Applying the Australian Quality Awards Criteria to a Clinical Chemistry Department', Quality Management in Health Care, 3, pp. 1 - 15, http://dx.doi.org/10.1097/00019514-199423000-00001

Proos AL; Sutton D; Burnett L; Shaw W, 1994, 'Taming the supplies and inventory process at Westmead Hospital', Qual Lett Healthc Lead, 6, pp. 83 - 86

Burnett L; Mackay MA; Costaganna G; Shaw W, 1993, 'A model quality system for Total Quality Management in the pathology laboratory', Clinical Biochemistry Reviews, 14, pp. 47 - 51

Burnett JR; Proos AL; Koutts J; Burnett L, 1993, 'Familial hypobetalipoproteinaemia: a rare presentation to the lipid clinic', The Medical Journal of Australia, 159, pp. 272 - 274

Burnett L, 1993, 'Introduction of total quality management into a clinical chemistry laboratory', Aust Clin Rev, 13, pp. 3 - 10

Banning J; Brown J; Hooper L; Hamilton J; Burnett JR; Burnett L, 1993, 'Reduction of errors in laboratory test reports using continuous quality improvement techniques', Clin Lab Manage Rev, 7, pp. 424 - 6

Burnett L, 1991, 'A tree-structure model for analyzing laboratory test costs.', Pathology, 23, pp. 172 - 176

Burnett L; Sugerman DA, 1991, 'Restrictions on ’multiple biochemical analyses’ profiling decreases usage of biochemistry test requests.', Pathology, 23, pp. 103 - 106

Burnett L, 1990, 'An audit of oral glucose tolerance test requests', The Medical Journal of Australia, 152, pp. 607 - 608

Williams S; Craig P; Cooksley W; Bye W; Bilous M; Grierson J; Nightingale B; Burnett L; Hensley W; Batey R; Farrell G, 1990, 'Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B', Aust N Z J Med, 20, pp. 9 - 19

Back to profile page